Huberman Lab avatar

Dexa/Huberman Lab

Supported byHuberman Lab
Learn more
Published Jan 12, 2017

Dave Morin Fireside with Josh Elman | #ProductSF

Delve into the minds of tech pioneers as Dave Morin shares his journey from shaping social giants like Apple and Facebook to pioneering biotech innovations aimed at revolutionizing mental health. This episode explores the strategic principles of product design, the challenges of scaling platforms, and the promising future of genomics in "Bio 2.0."
Episode Highlights
Greymatter logo

Topics covered

Popular Clips

Episode Highlights

  • Biotech Vision

    Dave Morin shares his enthusiasm for the future of biotechnology, which he terms "Bio 2.0." He believes we're at a pivotal moment similar to the early days of the internet and personal computing, where new tools like CRISPR and genomics are poised to revolutionize healthcare. Morin envisions a future where technology and biology intersect to rapidly cure diseases, akin to Moore's Law in computing.

    I really think that where we are in Biotech, I've been calling it Bio 2.0 is a really profound and important moment.

    ---

    He emphasizes the potential for biotechnology to address diseases that currently lack resources, predicting significant advancements in the coming decades 1.

       

    Mental Health

    Morin's personal connection to mental health drives his focus on finding a cure for depression through his project, Sunrise. He highlights the alarming statistics of depression, noting its rapid growth and significant impact on global health. Morin is committed to leveraging new genomic technologies to tackle this challenge, inspired by his father's lifelong struggle with depression.

    By 2030, it'll be the largest burden on global human health.

    ---

    His dedication to mental health reflects a broader mission to use biotechnology for addressing underfunded diseases, aiming for transformative change 1.

Related Episodes